Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AKBA Akebia Therapeutics, Inc.

交易中 05-17 15:00:30 EDT

1.15

+0.01

+0.44%

最高1.18	最低1.12	成交量182.91万
今开1.13	昨收1.14	日振幅5.26%
总市值2.40亿	流通市值2.34亿	总股本2.09亿
成交额211.35万	换手率0.89%	流通股本2.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AKBA","market":"US","secType":"STK","nameCN":"Akebia Therapeutics, Inc.","latestPrice":1.145,"timestamp":1715972423952,"preClose":1.14,"halted":0,"volume":1829071,"delay":0,"floatShares":204399704,"shares":209372275,"eps":-0.22451,"marketStatus":"交易中","marketStatusCode":2,"change":0.005,"latestTime":"05-17 15:00:30 EDT","open":1.13,"high":1.18,"low":1.12,"amount":2113516.4158655996,"amplitude":0.052632,"askPrice":1.15,"askSize":440,"bidPrice":1.14,"bidSize":17496,"shortable":3,"etf":0,"ttmEps":-0.22451,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715976000000},"adr":0,"listingDate":1395288000000,"adjPreClose":1.14,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.13,"preClose":1.14,"latestTime":"09:29 EDT","volume":11102,"amount":12666.104159800001,"timestamp":1715952599913},"postHourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.14,"latestTime":"19:54 EDT","volume":100033,"amount":112882.9073,"timestamp":1715903672910},"volumeRatio":0.767348},"requestUrl":"/m/hq/s/AKBA","defaultTab":"news","newsList":[{"id":"2434771925","title":"Akebia Therapeutics, Inc.盘中异动 股价大跌5.00%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434771925","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434771925?lang=zh_cn&edition=full","pubTime":"2024-05-09 01:23","pubTimestamp":1715189037,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日01时23分，Akebia Therapeutics, Inc.股票出现异动，股价急速下挫5.00%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Brainstorm Cell Therapeutics Inc.涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为246.35%、106.69%、38.34%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Geovax Labs Inc C/Wts 29/09/2025、Cel-Sci Corporation，振幅分别为80.33%、60.74%、51.50%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家全面整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090123577a58c763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090123577a58c763&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433878763","title":"Akebia Therapeutics, Inc.盘中异动 股价大跌5.37%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433878763","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433878763?lang=zh_cn&edition=full","pubTime":"2024-05-08 00:22","pubTimestamp":1715098949,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日00时22分，Akebia Therapeutics, Inc.股票出现异动，股价快速跳水5.37%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Carmell Corp C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1436.16%、223.88%、185.81%，振幅较大的相关个股有Avenue Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、珐博进，振幅分别为42.73%、41.69%、41.38%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家全面整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508002229861eb849&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508002229861eb849&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433207000","title":"Akebia Therapeutics Inc    预计每股亏损 8 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433207000","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433207000?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:35","pubTimestamp":1715088932,"startTime":"0","endTime":"0","summary":"   * Akebia Therapeutics Inc    预计将在5月9日公布截至2024年3月31日的季度收入报告。* LSEG 分析师对 Akebia Therapeutics Inc 的平均预期是每股亏损 8 美分。* 华尔街对 Akebia Therapeutics Inc 的 12 个月目标价中位数为 5.00 美元，高于其上一次收盘价 1.49 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432902076","title":"Akebia Therapeutics Inc    预计每股亏损 8 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432902076","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432902076?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:33","pubTimestamp":1714750429,"startTime":"0","endTime":"0","summary":"   * Akebia Therapeutics Inc    预计将在5月9日公布截至2024年3月31日的季度收入报告。* LSEG 分析师对 Akebia Therapeutics Inc 的平均预期是每股亏损 8 美分。* 华尔街对 Akebia Therapeutics Inc 的 12 个月目标价中位数为 5.00 美元，高于上一次收盘价 1.30 美元。5月3日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432697099","title":"Akebia Therapeutics, Inc.盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432697099","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432697099?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:31","pubTimestamp":1714743067,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时31分，Akebia Therapeutics, Inc.股票出现波动，股价快速上涨5.00%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为59.73%、21.05%、10.23%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Relay Therapeutics, Inc.、Karyopharm Therapeutics Inc.，振幅分别为15.86%、13.56%、6.94%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家全面整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032131077925c0a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032131077925c0a8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432795813","title":"Akebia Therapeutics, Inc.盘中异动 急速上涨5.24%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432795813","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432795813?lang=zh_cn&edition=full","pubTime":"2024-05-03 03:57","pubTimestamp":1714679840,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日03时57分，Akebia Therapeutics, Inc.股票出现异动，股价快速上涨5.24%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Effector Therapeutics Inc C/Wts 31/12/2025 、Sensei Biotherapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为4756.84%、711.61%、163.51%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为169.34%、86.54%、49.56%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家全面整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030357207925b5a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030357207925b5a6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431200683","title":"Akebia Therapeutics, Inc.盘中异动 早盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431200683","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431200683?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:31","pubTimestamp":1714487501,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日22时31分，Akebia Therapeutics, Inc.股票出现异动，股价大幅下跌5.00%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Eliem Therapeutics, Inc、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1118.56%、212.61%、15.74%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Eliem Therapeutics, Inc、Cyclacel Pharmaceuticals, Inc.，振幅分别为46.79%、41.43%、40.44%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc是一家全面整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302231417a57c366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302231417a57c366&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426263645","title":"Akebia Therapeutics, Inc.盘中异动 股价大跌5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426263645","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426263645?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:08","pubTimestamp":1712844496,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时08分，Akebia Therapeutics, Inc.股票出现异动，股价大幅下挫5.13%。截至发稿，该股报1.48美元/股，成交量83.954万股，换手率0.40%，振幅4.17%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Alpine Immune Sciences, Inc.涨幅较大，Scisparc Ltd.、Aptevo Therapeutics Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为411.41%、373.11%、318.18%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Adial Pharmaceuticals, Inc，振幅分别为50.92%、46.31%、28.33%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc 是一家完全整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041122081687e7fa59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041122081687e7fa59&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426497884","title":"Akebia Therapeutics, Inc.盘中异动 快速上涨5.19%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426497884","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426497884?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:32","pubTimestamp":1712755931,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时32分，Akebia Therapeutics, Inc.股票出现异动，股价快速拉升5.19%。截至发稿，该股报1.62美元/股，成交量86.2063万股，换手率0.41%，振幅2.65%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为917.10%、62.55%、22.10%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、X4制药、Abvc Biopharma, Inc.，振幅分别为28.32%、13.39%、10.17%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc 是一家完全整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213211861e4a47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213211861e4a47&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424313065","title":"Akebia Therapeutics, Inc.盘中异动 早盘大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424313065","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424313065?lang=zh_cn&edition=full","pubTime":"2024-04-04 22:24","pubTimestamp":1712240657,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日22时24分，Akebia Therapeutics, Inc.股票出现波动，股价急速拉升5.03%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Tc Biopharm  Plc、Effector Therapeutics, Inc.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为2839.12%、94.66%、53.68%，振幅较大的相关个股有Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc.，振幅分别为90.00%、70.00%、48.48%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc 是一家完全整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042224187a51070e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042224187a51070e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423718171","title":"隔夜美股全复盘(3.29)| 美股Q1收官，全市场市值增4万亿美元，英伟达市值增万亿美元；小米集团ADR涨逾12%，小米宣布SU7标准版起售价为21.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2423718171","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2423718171?lang=zh_cn&edition=full","pubTime":"2024-03-29 08:17","pubTimestamp":1711671454,"startTime":"0","endTime":"0","summary":"美股Q1收官，全市场市值增4万亿美元，英伟达市值增万亿美元；小米集团ADR涨逾12%，小米宣布SU7标准版起售价为21.59万元","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/713609","is_publish_highlight":false,"gpt_icon":0},{"id":"2422729489","title":"美国 FDA 批准 Akebia 的贫血症药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2422729489","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422729489?lang=zh_cn&edition=full","pubTime":"2024-03-28 08:44","pubTimestamp":1711586642,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社3月28日 - 美国食品和药物管理局周三批准了Akebia Therapeutics公司的  药物，用于治疗透析患者因慢性肾病引起的贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422615752","title":"Akebia Therapeutics, Inc.盘中异动 大幅跳水5.43%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422615752","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422615752?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:32","pubTimestamp":1711459953,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时32分，Akebia Therapeutics, Inc.股票出现异动，股价急速跳水5.43%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Stoke Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Abvc Biopharma, Inc.涨幅较大，Abvc Biopharma, Inc.、Xtl生物制药、Stoke Therapeutics, Inc.较为活跃，换手率分别为100.08%、11.15%、10.19%，振幅较大的相关个股有Stoke Therapeutics, Inc.、Molecular Templates, Inc.、Bio-Path Holdings, Inc.，振幅分别为24.77%、14.64%、12.96%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc 是一家完全整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262132338b6577d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262132338b6577d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421481247","title":"Akebia Therapeutics, Inc.盘中异动 急速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421481247","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421481247?lang=zh_cn&edition=full","pubTime":"2024-03-22 22:06","pubTimestamp":1711116366,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日22时06分，Akebia Therapeutics, Inc.股票出现异动，股价大幅拉升5.15%。Akebia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Matinas Biopharma Holdings, Inc.、Outlook Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Outlook Therapeutics, Inc.、180 Life Sciences Corp.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为54.57%、15.89%、11.11%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、Nutriband Inc C/Wts 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为53.68%、42.17%、42.00%。Akebia Therapeutics, Inc.公司简介：Akebia Therapeutics Inc 是一家完全整合的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222206067a4e8aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222206067a4e8aec&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akebia.com","stockEarnings":[{"period":"1week","weight":-0.1429},{"period":"1month","weight":-0.1857},{"period":"3month","weight":-0.2138},{"period":"6month","weight":0.14},{"period":"1year","weight":0.0088},{"period":"ytd","weight":-0.0806}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Akebia Therapeutics, Inc.依法于2007年2月27日在特拉华州成立。该公司是一家致力于：基于缺氧诱导因子的新型生物性专有疗法的研发，肾脏疾病患者所需产品商业化应用的生物制药公司。HIF是人体内红细胞生成和潜在贫血治疗新机制的主要调节器。Akebia的候选主导产品AKB-6548作为一种每日一次的口服产品，已经成功完成2a期概念验证。研究表明AKB-6548可以在不需要透析的情况下安全有效地提高继发性贫血和慢性肾病患者的血红蛋白水平。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.003024},{"month":2,"riseRate":0.5,"avgChangeRate":0.084528},{"month":3,"riseRate":0.4,"avgChangeRate":-0.086789},{"month":4,"riseRate":0.454545,"avgChangeRate":0.001273},{"month":5,"riseRate":0.545455,"avgChangeRate":0.024383},{"month":6,"riseRate":0.7,"avgChangeRate":0.054944},{"month":7,"riseRate":0.4,"avgChangeRate":0.012909},{"month":8,"riseRate":0.3,"avgChangeRate":-0.039628},{"month":9,"riseRate":0.4,"avgChangeRate":-0.040727},{"month":10,"riseRate":0,"avgChangeRate":-0.147974},{"month":11,"riseRate":0.7,"avgChangeRate":0.160501},{"month":12,"riseRate":0.5,"avgChangeRate":0.100433}],"exchange":"NASDAQ","name":"Akebia Therapeutics, Inc.","nameEN":"Akebia Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Akebia Therapeutics, Inc.(AKBA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Akebia Therapeutics, Inc.,AKBA,Akebia Therapeutics, Inc.股票,Akebia Therapeutics, Inc.股票老虎,Akebia Therapeutics, Inc.股票老虎国际,Akebia Therapeutics, Inc.行情,Akebia Therapeutics, Inc.股票行情,Akebia Therapeutics, Inc.股价,Akebia Therapeutics, Inc.股市,Akebia Therapeutics, Inc.股票价格,Akebia Therapeutics, Inc.股票交易,Akebia Therapeutics, Inc.股票购买,Akebia Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Akebia Therapeutics, Inc.(AKBA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况